Roger Camble

Title: Roger Camble: Innovator in G-CSF Derivatives

Introduction

Roger Camble is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of biochemistry, particularly in the development of granulocyte colony-stimulating factor (G-CSF) derivatives. With a total of 4 patents to his name, his work has implications for medical treatments and therapies.

Latest Patents

Among his latest patents is a conjugate of a solution stable G-CSF derivative and a water-soluble polymer. This invention provides a stable physiologically active substance derived from naturally occurring G-CSF. Another significant patent involves polypeptide derivatives of G-CSF, which maintain at least one biological property of the native G-CSF while exhibiting enhanced solution stability. These derivatives can be utilized in various applications, including the transformation of host cells in culture.

Career Highlights

Roger Camble has worked with prominent companies such as Imperial Chemical Industries Limited and Zeneca Limited. His experience in these organizations has contributed to his expertise in the field of biochemistry and patent development.

Collaborations

Throughout his career, Roger has collaborated with notable colleagues, including David Timms and Anthony J Wilkinson. These partnerships have likely enriched his research and innovation efforts.

Conclusion

Roger Camble's contributions to the field of G-CSF derivatives highlight his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to developing solutions that can have a meaningful impact on healthcare.